Status:

COMPLETED

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Lead Sponsor:

Cancer Trials Ireland

Conditions:

Leukemia

Eligibility:

All Genders

Up to 64 years

Phase:

PHASE2

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as fludarabine and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividin...

Detailed Description

OBJECTIVES: Primary * Evaluate the efficacy, in terms of complete remission rate, of fludarabine phosphate, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia. Secondary ...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of chronic lymphocytic leukemia
  • Stage I-IV disease (Binet stage progressive A, B, C)
  • CD5 and CD23 positive
  • Untreated OR relapsed/resistant disease after combination chemotherapy or rituximab
  • No 17p deletion
  • PATIENT CHARACTERISTICS:
  • WHO performance status 0-2
  • Life expectancy \> 1 year
  • Creatinine clearance ≥ 50 mL/min
  • HIV negative
  • Not pregnant or nursing
  • Negative pregnancy test
  • Fertile patients must use effective contraception
  • No other concurrent malignancy except for noninvasive cervical cancer or localized nonmelanomatous skin cancer
  • No history of anaphylaxis to mouse-derived humanized monoclonal antibody
  • No other severe concurrent (e.g., cardiac or pulmonary) diseases or mental disorders that could interfere with ability to participate in the study
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Exclusion

    Key Trial Info

    Start Date :

    August 18 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 21 2019

    Estimated Enrollment :

    52 Patients enrolled

    Trial Details

    Trial ID

    NCT00812669

    Start Date

    August 18 2008

    End Date

    November 21 2019

    Last Update

    July 8 2025

    Active Locations (7)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (7 locations)

    1

    Tallaght University Hospital

    Dublin, Leinster, Ireland

    2

    Cork University Hospital

    Cork, Munster, Ireland

    3

    St. James's Hospital

    Dublin, Ireland, 8

    4

    University College Hospital

    Galway, Ireland